Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
Market Analysis and Insights: Global Digital Biomarker Market
The global Digital Biomarker market size is projected to reach US$ 22360 million by 2028, from US$ 387.2 million in 2021, at a CAGR of 82.5% during 2022-2028.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Biomarker market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Biomarker market.
Global Digital Biomarker Scope and Market Size
Digital Biomarker market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Digital Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Passive Digital Biomarker
- Active Digital Biomarker
Segment by Application
- Clinical Disease
- Daily Health
By Company
- Philips
- Johnson & Johnson
- Pfizer
- GE Healthcare
- Novartis
- Apple
- Sanofi
- GlaxoSmithKline
- Bayer
- Merck
- Abbott Laboratories
- Asahi Kasei
- Biogen
- Koneksa Health
- Roche
- Huma Therapeutics
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Digital Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Passive Digital Biomarker
- 1.2.3 Active Digital Biomarker
- 1.3 Market by Application
- 1.3.1 Global Digital Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Clinical Disease
- 1.3.3 Daily Health
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Digital Biomarker Market Perspective (2017-2028)
- 2.2 Digital Biomarker Growth Trends by Region
- 2.2.1 Digital Biomarker Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Digital Biomarker Historic Market Size by Region (2017-2022)
- 2.2.3 Digital Biomarker Forecasted Market Size by Region (2023-2028)
- 2.3 Digital Biomarker Market Dynamics
- 2.3.1 Digital Biomarker Industry Trends
- 2.3.2 Digital Biomarker Market Drivers
- 2.3.3 Digital Biomarker Market Challenges
- 2.3.4 Digital Biomarker Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Digital Biomarker Players by Revenue
- 3.1.1 Global Top Digital Biomarker Players by Revenue (2017-2022)
- 3.1.2 Global Digital Biomarker Revenue Market Share by Players (2017-2022)
- 3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Digital Biomarker Revenue
- 3.4 Global Digital Biomarker Market Concentration Ratio
- 3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2021
- 3.5 Digital Biomarker Key Players Head office and Area Served
- 3.6 Key Players Digital Biomarker Product Solution and Service
- 3.7 Date of Enter into Digital Biomarker Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Biomarker Breakdown Data by Type
- 4.1 Global Digital Biomarker Historic Market Size by Type (2017-2022)
- 4.2 Global Digital Biomarker Forecasted Market Size by Type (2023-2028)
5 Digital Biomarker Breakdown Data by Application
- 5.1 Global Digital Biomarker Historic Market Size by Application (2017-2022)
- 5.2 Global Digital Biomarker Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Digital Biomarker Market Size (2017-2028)
- 6.2 North America Digital Biomarker Market Size by Type
- 6.2.1 North America Digital Biomarker Market Size by Type (2017-2022)
- 6.2.2 North America Digital Biomarker Market Size by Type (2023-2028)
- 6.2.3 North America Digital Biomarker Market Share by Type (2017-2028)
- 6.3 North America Digital Biomarker Market Size by Application
- 6.3.1 North America Digital Biomarker Market Size by Application (2017-2022)
- 6.3.2 North America Digital Biomarker Market Size by Application (2023-2028)
- 6.3.3 North America Digital Biomarker Market Share by Application (2017-2028)
- 6.4 North America Digital Biomarker Market Size by Country
- 6.4.1 North America Digital Biomarker Market Size by Country (2017-2022)
- 6.4.2 North America Digital Biomarker Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Digital Biomarker Market Size (2017-2028)
- 7.2 Europe Digital Biomarker Market Size by Type
- 7.2.1 Europe Digital Biomarker Market Size by Type (2017-2022)
- 7.2.2 Europe Digital Biomarker Market Size by Type (2023-2028)
- 7.2.3 Europe Digital Biomarker Market Share by Type (2017-2028)
- 7.3 Europe Digital Biomarker Market Size by Application
- 7.3.1 Europe Digital Biomarker Market Size by Application (2017-2022)
- 7.3.2 Europe Digital Biomarker Market Size by Application (2023-2028)
- 7.3.3 Europe Digital Biomarker Market Share by Application (2017-2028)
- 7.4 Europe Digital Biomarker Market Size by Country
- 7.4.1 Europe Digital Biomarker Market Size by Country (2017-2022)
- 7.4.2 Europe Digital Biomarker Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Digital Biomarker Market Size (2017-2028)
- 8.2 Asia-Pacific Digital Biomarker Market Size by Type
- 8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Digital Biomarker Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Digital Biomarker Market Size by Application
- 8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Digital Biomarker Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Digital Biomarker Market Size by Region
- 8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Digital Biomarker Market Size (2017-2028)
- 9.2 Latin America Digital Biomarker Market Size by Type
- 9.2.1 Latin America Digital Biomarker Market Size by Type (2017-2022)
- 9.2.2 Latin America Digital Biomarker Market Size by Type (2023-2028)
- 9.2.3 Latin America Digital Biomarker Market Share by Type (2017-2028)
- 9.3 Latin America Digital Biomarker Market Size by Application
- 9.3.1 Latin America Digital Biomarker Market Size by Application (2017-2022)
- 9.3.2 Latin America Digital Biomarker Market Size by Application (2023-2028)
- 9.3.3 Latin America Digital Biomarker Market Share by Application (2017-2028)
- 9.4 Latin America Digital Biomarker Market Size by Country
- 9.4.1 Latin America Digital Biomarker Market Size by Country (2017-2022)
- 9.4.2 Latin America Digital Biomarker Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Digital Biomarker Market Size (2017-2028)
- 10.2 Middle East & Africa Digital Biomarker Market Size by Type
- 10.2.1 Middle East & Africa Digital Biomarker Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Digital Biomarker Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Digital Biomarker Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Digital Biomarker Market Size by Application
- 10.3.1 Middle East & Africa Digital Biomarker Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Digital Biomarker Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Digital Biomarker Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Digital Biomarker Market Size by Country
- 10.4.1 Middle East & Africa Digital Biomarker Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Digital Biomarker Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Philips
- 11.1.1 Philips Company Details
- 11.1.2 Philips Business Overview
- 11.1.3 Philips Digital Biomarker Introduction
- 11.1.4 Philips Revenue in Digital Biomarker Business (2017-2022)
- 11.1.5 Philips Recent Developments
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Details
- 11.2.2 Johnson & Johnson Business Overview
- 11.2.3 Johnson & Johnson Digital Biomarker Introduction
- 11.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2017-2022)
- 11.2.5 Johnson & Johnson Recent Developments
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Pfizer Business Overview
- 11.3.3 Pfizer Digital Biomarker Introduction
- 11.3.4 Pfizer Revenue in Digital Biomarker Business (2017-2022)
- 11.3.5 Pfizer Recent Developments
- 11.4 GE Healthcare
- 11.4.1 GE Healthcare Company Details
- 11.4.2 GE Healthcare Business Overview
- 11.4.3 GE Healthcare Digital Biomarker Introduction
- 11.4.4 GE Healthcare Revenue in Digital Biomarker Business (2017-2022)
- 11.4.5 GE Healthcare Recent Developments
- 11.5 Novartis
- 11.5.1 Novartis Company Details
- 11.5.2 Novartis Business Overview
- 11.5.3 Novartis Digital Biomarker Introduction
- 11.5.4 Novartis Revenue in Digital Biomarker Business (2017-2022)
- 11.5.5 Novartis Recent Developments
- 11.6 Apple
- 11.6.1 Apple Company Details
- 11.6.2 Apple Business Overview
- 11.6.3 Apple Digital Biomarker Introduction
- 11.6.4 Apple Revenue in Digital Biomarker Business (2017-2022)
- 11.6.5 Apple Recent Developments
- 11.7 Sanofi
- 11.7.1 Sanofi Company Details
- 11.7.2 Sanofi Business Overview
- 11.7.3 Sanofi Digital Biomarker Introduction
- 11.7.4 Sanofi Revenue in Digital Biomarker Business (2017-2022)
- 11.7.5 Sanofi Recent Developments
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Company Details
- 11.8.2 GlaxoSmithKline Business Overview
- 11.8.3 GlaxoSmithKline Digital Biomarker Introduction
- 11.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2017-2022)
- 11.8.5 GlaxoSmithKline Recent Developments
- 11.9 Bayer
- 11.9.1 Bayer Company Details
- 11.9.2 Bayer Business Overview
- 11.9.3 Bayer Digital Biomarker Introduction
- 11.9.4 Bayer Revenue in Digital Biomarker Business (2017-2022)
- 11.9.5 Bayer Recent Developments
- 11.10 Merck
- 11.10.1 Merck Company Details
- 11.10.2 Merck Business Overview
- 11.10.3 Merck Digital Biomarker Introduction
- 11.10.4 Merck Revenue in Digital Biomarker Business (2017-2022)
- 11.10.5 Merck Recent Developments
- 11.11 Abbott Laboratories
- 11.11.1 Abbott Laboratories Company Details
- 11.11.2 Abbott Laboratories Business Overview
- 11.11.3 Abbott Laboratories Digital Biomarker Introduction
- 11.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2017-2022)
- 11.11.5 Abbott Laboratories Recent Developments
- 11.12 Asahi Kasei
- 11.12.1 Asahi Kasei Company Details
- 11.12.2 Asahi Kasei Business Overview
- 11.12.3 Asahi Kasei Digital Biomarker Introduction
- 11.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2017-2022)
- 11.12.5 Asahi Kasei Recent Developments
- 11.13 Biogen
- 11.13.1 Biogen Company Details
- 11.13.2 Biogen Business Overview
- 11.13.3 Biogen Digital Biomarker Introduction
- 11.13.4 Biogen Revenue in Digital Biomarker Business (2017-2022)
- 11.13.5 Biogen Recent Developments
- 11.14 Koneksa Health
- 11.14.1 Koneksa Health Company Details
- 11.14.2 Koneksa Health Business Overview
- 11.14.3 Koneksa Health Digital Biomarker Introduction
- 11.14.4 Koneksa Health Revenue in Digital Biomarker Business (2017-2022)
- 11.14.5 Koneksa Health Recent Developments
- 11.15 Roche
- 11.15.1 Roche Company Details
- 11.15.2 Roche Business Overview
- 11.15.3 Roche Digital Biomarker Introduction
- 11.15.4 Roche Revenue in Digital Biomarker Business (2017-2022)
- 11.15.5 Roche Recent Developments
- 11.16 Huma Therapeutics
- 11.16.1 Huma Therapeutics Company Details
- 11.16.2 Huma Therapeutics Business Overview
- 11.16.3 Huma Therapeutics Digital Biomarker Introduction
- 11.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2017-2022)
- 11.16.5 Huma Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer